Investments
752Portfolio Exits
185Funds
17Service Providers
1About InterWest Partners
InterWest Partners is a Silicon Valley based VC firm. InterWest focuses primarily on providing venture capital to early stage companies. This includes, per the firm, funding company building, including de novo company formation at the firm. On the life sciences side, InterWest offers venture capital to an array of early-stage companies, including funding preclinical companies. The firm will also consider investing in - or starting in house - new companies around clinical or commercial stage assets. On the IT side, InterWest provides venture capital to early-stage companies with near-term ROI-based value propositions. The firm typically favors funding development stage companies. InterWest invests an average of about $10 - 15 million of venture capital over the span of their involvement with each company in their portfolio.
Want to inform investors similar to InterWest Partners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing InterWest Partners
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find InterWest Partners in 2 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
115 items
Fitness Tech
227 items
We define fitness tech as companies leveraging software and technology to augment approaches to developing or maintaining physical fitness. Companies in this category develop tools and services including workout apps, wearables, and connected fitness equipment.
Latest InterWest Partners News
Nov 9, 2022
IN INITIAL ROUND OF VENTURE CAPITAL FUNDING under the stewardship of President and CEO Steven Gillis, PhD. The private financing was provided by five West Coast venture firms: Enterprise Partners (Newport Beach, Calif.), Interwest Partners (Menlo Park, Calif.), Olympic Venture Partners (Kirkland, Wash.), Forward Ventures (San Diego) and Kleiner Perkins Caufield and Byers (Menlo Park). Gillis was the founder of Immunex and served as the Seattle-based biotech's exec VP-R&D. Corixa, also based in Seattle, was founded in September 1994. Gillis was acting CEO of Immunex following its merger with Lederle in 1993. He resumed his exec VP duties when Lederle exec Edward Fritzby was named Immunex chairman and CEO in January 1994. You may also be interested in... All fields are required. For multiple recipients, separate email addresses with a semicolon. Please make sure all fields are completed. Please enter a valid e-mail address Please make sure you have filled out all fields Please make sure you have filled out all fields Subject: Corixa completes $15 mil. Add a personalized message to your email Cancel Send Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe. Sign In To Set a Search Alert Finish creating your saved search alert after you sign in
InterWest Partners Investments
752 Investments
InterWest Partners has made 752 investments. Their latest investment was in GoCheck Kids as part of their Series B - II on October 10, 2021.
InterWest Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
10/22/2021 | Series B - II | GoCheck Kids | $10M | No | 1 | |
11/2/2020 | Unattributed VC | Welltok | $17.38M | No | 2 | |
7/27/2020 | Series E - V | Welltok | $10.44M | No | 1 | |
11/13/2019 | Series C | |||||
8/7/2019 | Series D |
Date | 10/22/2021 | 11/2/2020 | 7/27/2020 | 11/13/2019 | 8/7/2019 |
|---|---|---|---|---|---|
Round | Series B - II | Unattributed VC | Series E - V | Series C | Series D |
Company | GoCheck Kids | Welltok | Welltok | ||
Amount | $10M | $17.38M | $10.44M | ||
New? | No | No | No | ||
Co-Investors | |||||
Sources | 1 | 2 | 1 |
InterWest Partners Portfolio Exits
185 Portfolio Exits
InterWest Partners has 185 portfolio exits. Their latest portfolio exit was Braze on November 17, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
11/17/2021 | IPO | Public | 14 | ||
10/14/2021 | Acquired | 2 | |||
10/7/2021 | Acquired | 4 | |||
Date | 11/17/2021 | 10/14/2021 | 10/7/2021 | ||
|---|---|---|---|---|---|
Exit | IPO | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 14 | 2 | 4 |
InterWest Partners Acquisitions
5 Acquisitions
InterWest Partners acquired 5 companies. Their latest acquisition was TheraTx on June 24, 1994.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
6/24/1994 | Series B | $12.8M | IPO | 1 | ||
2/1/1994 | Series B | |||||
6/30/1993 | Series B | |||||
12/18/1992 | Series A | |||||
11/1/1983 | Series A |
Date | 6/24/1994 | 2/1/1994 | 6/30/1993 | 12/18/1992 | 11/1/1983 |
|---|---|---|---|---|---|
Investment Stage | Series B | Series B | Series B | Series A | Series A |
Companies | |||||
Valuation | |||||
Total Funding | $12.8M | ||||
Note | IPO | ||||
Sources | 1 |
InterWest Partners Fund History
17 Fund Histories
InterWest Partners has 17 funds, including InterWest Partners X.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
8/11/2008 | InterWest Partners X | Early-Stage Venture Capital | Closed | $650M | 1 |
9/7/2004 | InterWest Partners IX | Early-Stage Venture Capital | Closed | $600M | 2 |
12/31/2000 | InterWest Investors QVIII | Early-Stage Venture Capital | Closed | $22M | 1 |
1/1/2000 | InterWest Partners VIII | ||||
1/1/2000 | InterWest Investors Q-VIII |
Closing Date | 8/11/2008 | 9/7/2004 | 12/31/2000 | 1/1/2000 | 1/1/2000 |
|---|---|---|---|---|---|
Fund | InterWest Partners X | InterWest Partners IX | InterWest Investors QVIII | InterWest Partners VIII | InterWest Investors Q-VIII |
Fund Type | Early-Stage Venture Capital | Early-Stage Venture Capital | Early-Stage Venture Capital | ||
Status | Closed | Closed | Closed | ||
Amount | $650M | $600M | $22M | ||
Sources | 1 | 2 | 1 |
InterWest Partners Team
27 Team Members
InterWest Partners has 27 team members, including current Chief Financial Officer, Karen Wilson.
Name | Work History | Title | Status |
|---|---|---|---|
Karen Wilson | Chief Financial Officer | Current | |
Name | Karen Wilson | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Chief Financial Officer | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.